Original Research
Published on 08 Jan 2024
A real-world study of PARP inhibitors in 75 patients with platinum-sensitive recurrent ovarian cancer from China
in Gynecological Oncology
- 3,296 views
- 3 citations
Original Research
Published on 08 Jan 2024
in Gynecological Oncology
Original Research
Published on 08 Jan 2024
in Cancer Imaging and Image-directed Interventions
Original Research
Published on 08 Jan 2024
in Breast Cancer
Original Research
Published on 08 Jan 2024
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Systematic Review
Published on 08 Jan 2024
in Breast Cancer
Review
Published on 08 Jan 2024
in Molecular and Cellular Oncology
Review
Published on 08 Jan 2024
in Cancer Metabolism
Case Report
Published on 08 Jan 2024
in Radiation Oncology
Original Research
Published on 08 Jan 2024
in Gastrointestinal Cancers: Colorectal Cancer
Case Report
Published on 08 Jan 2024
in Pediatric Oncology
Case Report
Published on 08 Jan 2024
in Breast Cancer
Original Research
Published on 08 Jan 2024
in Radiation Oncology
Case Report
Published on 08 Jan 2024
in Cancer Genetics
Original Research
Published on 08 Jan 2024
in Thoracic Oncology
Perspective
Published on 08 Jan 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 08 Jan 2024
in Thoracic Oncology